Replies to post #95370 on $heff's $tation of $tocks & $olid DD

[kei]

XXII --> October 5-7
http://ih.advfn.com/p.php?pid=nmona&article=72532772

Mr. Vail will share more detailed consumer and physician survey results October 5-7 at BioNetwork’s Partnering Summit in Laguna Niguel, California. BioNetwork’s annual event brings together the decision-makers and business development executives from the pharmaceutical and biotechnology industries to initiate strategic partnerships. Mr. Vail will also share an overview of the now 15 completed and 19 on-going independent clinical research studies using the Company’s Very Low Nicotine tobacco. Since 2015, the number of published studies using 22nd Century’s proprietary Very Low Nicotine tobacco has more than doubled. The results of these studies have been overwhelmingly favorable. Of notable importance, an independent clinical study, funded in part by the FDA, and published in the October 2015 issue of The New England Journal of Medicine, found that smokers of 22nd Century’s VLN cigarettes consumed far fewer cigarettes per day and doubled their quit attempts versus smokers of conventional cigarettes.

[$heff]

$XXII..$1.49....key information will be shared at their upcoming meeting this week. Good catalyst.